Hydrastis Canadensis Pellet
Product Images NDC 0220-2559

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrastis Canadensis (NDC 0220-2559). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Boiron, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Hydcan30x)

Label (Hydcan30x)
This is a description of a homeopathic medicine called Hydrastis canadensis, which comes in pellet form in a tube. The drug facts include that the active ingredient is 0.443 mg per pellet, the intended use is for post-nasal drip, and the medication should be taken under the tongue. It is advised that if symptoms persist for more than three days or worsen, a doctor should be consulted. Dispersal instructions are included, and the manufacturer is Boiron Inc. Inactive ingredients include lactose and sucrose.*
FDA Label Image

Hydrastis Canadensis 30x Label

Hydrastis Canadensis 30x Label
This is a description of Hydrastis Canadensis, which is a homeopathic medicine made in France. It contains hydrastine, berberine alkaloids and is used to relieve symptoms such as post-nasal drip. The user should dissolve 5 pellets under the tongue 3 times a day until the symptoms are relieved, or as directed by a doctor. The drug facts should be considered before use, and if symptoms persist for more than 3 days or worsen, a doctor should be consulted. Children should not handle the pellets, and they should be kept out of their reach.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.